Nanoparticles in Cancer Theranostics: Current Progress in Cancer Management
Editat de Prudhvi Lal Bhukya, Neelam Thakuren Limba Engleză Hardback – 7 oct 2024
Preț: 794.43 lei
Preț vechi: 1069.20 lei
-26% Nou
Puncte Express: 1192
Preț estimativ în valută:
152.04€ • 160.40$ • 126.71£
152.04€ • 160.40$ • 126.71£
Carte tipărită la comandă
Livrare economică 02-16 ianuarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9781032732282
ISBN-10: 1032732288
Pagini: 370
Ilustrații: 166
Dimensiuni: 178 x 254 mm
Greutate: 0.84 kg
Ediția:1
Editura: CRC Press
Colecția CRC Press
Locul publicării:Boca Raton, United States
ISBN-10: 1032732288
Pagini: 370
Ilustrații: 166
Dimensiuni: 178 x 254 mm
Greutate: 0.84 kg
Ediția:1
Editura: CRC Press
Colecția CRC Press
Locul publicării:Boca Raton, United States
Public țintă
Academic, Postgraduate, and Professional ReferenceCuprins
Part I: Introduction, Chapter 1. An Introduction to Fundamentals of Cancer Cell Biology, Chapter 2. Recent Patterns of Cancer Incidence and Mortality: Global and Indian Scenario, Chapter 3. Nano-Bio Dynamics: Mechanisms and Challenges in Shaping Nanomaterials for Biomedical Use, Part II: Nanoparticles in Cancer Diagnosis, Chapter 4. Conventional Methods of Cancer Diagnosis, Chapter 5. Uncovering the Impact of Nanoparticles in Cancer Diagnosis, Chapter 6. Nano Contrast Agents: Illuminating Cancer Pathways for Precise Diagnosis, Chapter 7. Cancer Imaging Enhancement through Nanotechnology, Chapter 8. Cancer Detection: Nanodevices at the Forefront of Early Diagnosis, Part III: Nanoparticles in Cancer Therapy, Chapter 9. Conventional Methods of Cancer Therapy, Chapter 10. Exploring the Nanoparticles in Cancer treatment, Chapter 11. Lipid-based Nanoparticles to Diagnose and Cure Cancer, Chapter 12. Multifunctional Nanomaterials for Advanced Cancer Therapy, Chapter 13. Monoclonal Antibodies for Targeted Drug Delivery, Chapter 14. Nanoparticles in Immunotherapy for Viral-Related Cancers, Chapter 15. Sequential Catalytic Nanomedicine-enabled Chemotherapy-based Synergetic Cancer Treatments, Chapter 16. Strategies Using Nanomedicine to Manage Drug Resistance in Cancer
Notă biografică
Dr. Neelam Thakur has been serving as an Assistant Professor in the Department of Zoology at Sardar Patel University, Mandi, Himachal Pradesh, since the year 2022. She also holds the roles of Coordinator and Head of the Zoology Department at the same institution. Prior to her tenure at Sardar Patel University, she worked as an Associate Professor in the Department of Biosciences at Chandigarh University in Punjab. Dr. Thakur earned her Ph.D. in Genetics from Himachal Pradesh University in 2012. Following the completion of her Ph.D., she joined the Immunology lab at CSIR-Imtech, Chandigarh, as a Research Associate in 2012. Her research interests encompass various fields, including early diagnosis of tuberculosis and cancer, nanotechnology for cancer diagnostics and therapy, cytogenetic analysis of intellectually disabled individuals, and microbiome studies. She has a substantial research track record, having published more than 20 research papers in international journals of high repute. Additionally, she holds a patent titled Antigenic composition and method of expression thereof. Dr. Thakur has been recognized for her contributions to research with two Young Researchers Awards and one Eminent Researchers Award from government-registered societies and organizations.
Dr. Prudhvi Lal Bhukya is a Virologist currently serving as a Scientist at the ICMR-National Animal Resource Facility for Biomedical Research (NARFBR) in Hyderabad. Presently, he heads the Vaccine Testing Facility at NARFBR. His areas of expertise include preclinical vaccinology studies, host-viral interaction studies of emerging human viral infections, and the prevention and control of diseases, along with the development of tools to prevent outbreaks. He earned his Ph.D. from the ICMR-National Institute of Virology-Pune, focusing on the human hepatitis B virus. He has established his credentials through his work on HBV and HEV, as evidenced by his publication record. Dr. Bhukya has presented his research at numerous national and international conferences. His achievements include several publications in international journals of high repute.
Dr. Prudhvi Lal Bhukya is a Virologist currently serving as a Scientist at the ICMR-National Animal Resource Facility for Biomedical Research (NARFBR) in Hyderabad. Presently, he heads the Vaccine Testing Facility at NARFBR. His areas of expertise include preclinical vaccinology studies, host-viral interaction studies of emerging human viral infections, and the prevention and control of diseases, along with the development of tools to prevent outbreaks. He earned his Ph.D. from the ICMR-National Institute of Virology-Pune, focusing on the human hepatitis B virus. He has established his credentials through his work on HBV and HEV, as evidenced by his publication record. Dr. Bhukya has presented his research at numerous national and international conferences. His achievements include several publications in international journals of high repute.
Descriere
This book explores nanoparticles in cancer diagnosis and treatment, covering advanced detection methods, targeted therapies and innovative applications in radiotherapy and phototherapy. It addresses challenges, clinical trials and prospects making it a valuable resource for researchers, clinicians and students in oncology and nanotechnology.